---
figid: PMC7876991__or-45-04-7958-g05
figlink: pmc/articles/PMC7876991/figure/f6-or-0-0-7958/
number: F6
caption: 'A schematic diagram of potential regulation by CD44v10 on BCa cell proliferation.
  A CD44 activation model shows a phenotypic distinction between two subpopulations:
  BCa cells with inactive CD44 status (HA−/low) had higher proliferation and the subsets
  with active CD44 (HAhigh) grew slowly. The HA−/low cell preferentially expressed
  CD44v10 isoform (red dashed membrane). CD44v10 isoform probably facilitates BCa
  cell proliferation via regulating the p-ERK1/2-to-p-p38 ratio and AKT/mTOR signaling
  pathway. p-, phosphorylated; HA, hyaluronan; fl, Fluorescein-labeled; CD44v, CD44
  variant; BCa, breast cancer.'
pmcid: PMC7876991
papertitle: CD44 activation state regulated by the CD44v10 isoform determines breast
  cancer proliferation.
reftext: Qian Guo, et al. Oncol Rep. 2021 Apr;45(4):7.
pmc_ranked_result_index: '10029'
pathway_score: 0.956854
filename: or-45-04-7958-g05.jpg
figtitle: Schematic diagram of potential regulation by CD44v10 on BCa cell proliferation
year: '2021'
organisms:
- Mus musculus
- Rattus norvegicus
- Armoracia rusticana
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7876991__or-45-04-7958-g05.html
  '@type': Dataset
  description: 'A schematic diagram of potential regulation by CD44v10 on BCa cell
    proliferation. A CD44 activation model shows a phenotypic distinction between
    two subpopulations: BCa cells with inactive CD44 status (HA−/low) had higher proliferation
    and the subsets with active CD44 (HAhigh) grew slowly. The HA−/low cell preferentially
    expressed CD44v10 isoform (red dashed membrane). CD44v10 isoform probably facilitates
    BCa cell proliferation via regulating the p-ERK1/2-to-p-p38 ratio and AKT/mTOR
    signaling pathway. p-, phosphorylated; HA, hyaluronan; fl, Fluorescein-labeled;
    CD44v, CD44 variant; BCa, breast cancer.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK14
  - MAPK11
  - MAPK13
  - MAPK12
  - MAPK3
  - MAPK1
  - AKT2
  - AKT3
  - AKT1
  - MTOR
genes:
- word: р38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: р38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: р38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: р38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ΑΚΤ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: ΑΚΤ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: ΑΚΤ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: p-ERK1/2/p-p38
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: p-ERK1/2/p-p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: p-ERK1/2/p-p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: p-ERK1/2/p-p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: p-ERK1/2/p-p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: mTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
chemicals: []
diseases: []
figid_alias: PMC7876991__F6
redirect_from: /figures/PMC7876991__F6
figtype: Figure
---
